Kaimen Rigor reviewed

Rigor-Reviewed Manuscript

A large language model for complex cardiology care.

Name: Kaimen Rigor review — A large language model for complex cardiology care.
Item: A large language model for complex cardiology care.
Rating: 96
Author: Alpha1

O'Sullivan JW, Palepu A, Saab K, Weng WH, Amponsah DK, Cheng E, Cheng Y, Chu E, Desai Y, Elezaby A, Fazal M, Hussain T, Jain SS, Kim DS, Lan R, Li J, Tang W, Tapaskar N, Parikh V, Sandoval R, Spencer-Bonilla G, Wu B, Kulkarni K, Mansfield P, Webster D, Gottweis J, Barral J, Schaekermann M, Tanno R, Mahdavi SS, Natarajan V, Karthikesalingam A, Ashley E, Tu T

Paper source

Read full text (PMC)

Embed this Rigor badge

Kaimen Rigor review — 1.75★ (Critical), 0 critical, 5 high issues for “A large language model for complex cardiology care.”

Links back to this Kaimen Rigor review.

Alpha1 Editorial

This rigor review was examined and confirmed by Alpha1 Editorial · August 15, 2026

Read alongside

A large language model for complex cardiology care.

Read full text (PMC)

DOI

10.1038/s41591-025-04190-9

Share this Kaimen Rigor review

Post on X Share on LinkedIn Share via Email

Embed this Rigor badge

<a href="https://alpha1science.com/verify/8ab6e220-12e8-4828-b456-b9f6a160a566" target="_blank" rel="noopener">
  <img src="https://alpha1science.com/verify/8ab6e220-12e8-4828-b456-b9f6a160a566/badge" alt="Kaimen Rigor review — 1.75★ (Critical), 0 critical, 5 high issues for “A large language model for complex cardiology care.”" width="440" height="104" style="max-width:100%;height:auto" />
</a>

Every embed links back to this Kaimen Rigor review.

Record fingerprint

9da080894bcc5d7e9e269642c089bd6597ba779e149534d2492d9bb6f32796e3

Verify via API

Issued Aug 15, 2026Engine 7.39.0

Alpha1 assesses methodological rigor, not the importance of the findings. See how we calibrate →

Alpha¹ by Kaimen

Fetching the latest research

Kaimen Rigor reviewed

Rigor-Reviewed Manuscript

A large language model for complex cardiology care.

Paper source

A large language model for complex cardiology care.

Read full text (PMC)

Embed this Rigor badge

Links back to this Kaimen Rigor review.

Alpha1 Editorial

This rigor review was examined and confirmed by Alpha1 Editorial · August 15, 2026

Kaimen Rigor review

Kaimen Rigor reviewed

1.75 / 5

Critical — serious problems across many checks

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×4−2★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
ClaimsTreatment effect not shown to be clinically meaningful−0.5★
ReportingEthical approvals partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Biggest issues

01Efficacy rests on an unvalidated surrogate endpoint
highOverreachreviewer-assessedFull detail
The primary efficacy claim is that AMIE-assisted cardiologists produce 'preferable' assessments, with fewer errors and missing content, as rated by subspecialists. This is a surrogate outcome (subspecialist preference and error counts) rather than a hard clinical outcome. The paper does not demonstrate target engagement (e.g., PK/PD) nor cite validated evidence linking these surrogate measures to improved patient outcomes. The authors acknowledge this limitation: 'preference-based evaluation cannot definitively establish real-world clinical benefit.'
“preference-based evaluation cannot definitively establish real-world clinical benefit”
Find in source
02Treatment effect not shown to be clinically meaningful
highOverreachreviewer-assessedFull detail
The reported effect sizes are modest and not anchored to a minimal clinically important difference or clinical meaningfulness. For example, overall preference was 46.7% vs 32.7% (a 14% absolute difference), and error rates were 13.1% vs 24.3% (an 11.2% difference). These are statistically significant but the clinical significance is not established. The paper does not provide a benchmark for what constitutes a clinically meaningful improvement in these surrogate measures.
“subspecialists favored large language model-assisted responses overall, and for the management plan and diagnostic testing domains, with the remaining domains considered a tie”
Find in source
03Other integrity concern
mediumAuthenticityreviewer-assessedFull detail
Trial NCT06935253 was first submitted to ClinicalTrials.gov on 2025-04-11, after the registered study start date of 2025-01-10. Retrospective registration means the protocol and outcomes were not on the public record before the study ran, which is what prospective registration exists to establish.
NCT06935253
reviewer’s wording

Findings by category

101ArithmeticNumerical inconsistencies 302OverreachOverstated conclusions 103AuthenticityData authenticity concerns 104DisclosureReporting gaps 05AvailabilityNone found 06Copyedit6 minor suggestions

This Kaimen Rigor review uses Kaimen Rigor reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

A well-conducted and well-reported RCT of LLM assistance for general cardiologists, with minor reporting gaps (sex not reported, no named IRB, no power analysis, code repository not linked).

Both reviewers classified the study as interventional (RCT). The design is a randomized controlled trial with blinded evaluation. The main divergence between reviewers was on biological variables (Reviewer 1 pass, Reviewer 2 warn due to missing sex) and on key resources (Reviewer 1 pass, Reviewer 2 pass with a note on the Python version typo). The synthesized statuses reflect the more conservative reading where a reporting gap exists.

Numerical inconsistencies

1 finding · worst low

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Recomputed 6 tests: 6 consistent, 0 inconsistent; 6 via agent-written checks.

Overstated conclusions

3 findings · worst high

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Treatment effect not shown to be clinically meaningfulAssessed
Conclusions only partially backed by the presented evidenceAssessed

9 major claims checked against the paper's own evidence: 1 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Premise concern: surrogate not validated for clinical benefit; effect size not shown to be clinically meaningful.

Data authenticity concerns

1 finding · worst medium

An adversarial read for patterns associated with data that may not be genuine: results that look too clean, implausibly large effects, duplicated data or images, and methods that do not match the results reported.

Other integrity concernAssessed

4 integrity concerns flagged (0 high).

Reporting gaps

1 finding · worst medium

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Ethics/consent reporting incompleteAssessed

Eight Dimensions7 pass · 1 warn

The introduction cites WHO workforce shortages, HCM prevalence, and prior LLM studies, acknowledging the lack of RCTs and real-world data. The rationale for using genetic cardiomyopathies as an indicative example is logical. Limitations of prior work (e.g., simulated data, text-only) are explicitly addressed by using real-world multimodal data.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear premise: scarcity of subspecialist expertise, and prior work on LLMs in medicine is cited, with gaps identified.

Evidence

“Despite more than 500 observational LLM papers published in 2024, systematic reviews of LLMs in medicine have consistently shown a lack of RCTs”

Discussion ¶5Find in source

“This study probes the potential of LLMs to democratize subspecialist-level expertise by focusing on an indicative example: the domain of genetic cardiomyopathies like HCM.”

Introduction ¶4Find in source

“Compared to earlier studies relying on simulated or text-only data, our design represents a substantial advancement toward real-world clinical applicability.”

Introduction ¶4Find in source

PASSReviewer 2· 90% conf

The paper establishes a clear premise of subspecialist scarcity and the potential of LLMs, citing prior work and limitations.

Evidence

“Despite the potential of LLMs to enhance medical expertise, rigorous assessment of their performance remains scarce in medical specialties, with few openly available datasets for model evaluation and almost no randomized controlled trials (RCTs) performed.”

Introduction ¶2Find in source

“This study probes the potential of LLMs to democratize subspecialist-level expertise by focusing on an indicative example: the domain of genetic cardiomyopathies like HCM.”

Introduction ¶3Find in source

“Compared to earlier studies relying on simulated or text-only data, our design represents a substantial advancement toward real-world clinical applicability.”

Introduction ¶3Find in source

Randomization method is not explicitly detailed (e.g., random number generator), but the unit (general cardiologists) and counterbalanced design are stated. Blinding of subspecialists is clearly described. Power analysis is not reported, but the study is a pilot with 107 cases. Inclusion/exclusion criteria are implicit (consecutive patients from SCICD). Outlier handling is not explicitly addressed, but the analysis uses paired comparisons. Controls are inherent (unassisted arm). Independent replication is not applicable for a single RCT.

Sub-criteria

controlsADEQUATE

power analysisNOT REPORTED

blinding levelsADEQUATE

outlier handlingNOT REPORTED

randomization unitADEQUATE

inclusion exclusionINADEQUATE

randomization methodINADEQUATE

replicate distinctionN/A

independent replicationN/A

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 85% conf

The RCT design is well-described: randomization of cardiologists, blinding of subspecialist evaluators, and a pre-specified analysis plan.

Evidence

“One of the two general cardiologists was randomized to complete the assessment with the assistance of AMIE.”

MethodsFind in source

“The subspecialists were blinded to the source of each assessment, and the assessments were provided in a randomized order.”

MethodsFind in source

absence[Methods, Statistical analysis]

No power analysis is reported.

PASSReviewer 2· 85% conf

The RCT design is rigorous with randomization, blinding of evaluators, and a pre-specified analysis, though some details like allocation concealment are not reported.

Evidence

“One of the two general cardiologists was randomized to complete the assessment with the assistance of AMIE.”

MethodsFind in source

“The subspecialists were blinded to the source of each assessment, and the assessments were provided in a randomized order.”

MethodsFind in source

absence[Methods, Statistical analysis]

No power analysis is reported.

The paper reports median age (59 years, range 18-96) and the distribution of cardiac conditions. Sex is not explicitly reported in the main text, but the demographics are adequate for a clinical study. Age and health status are covered by the disease categories. Species/strain and housing are not applicable.

Sub-criteria

demographicsINADEQUATE

sex reportedNOT REPORTED

sex justifiedN/A

age weight healthADEQUATE

housing conditionsN/A

species strain sourceN/A

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 80% conf

Patient demographics (age, sex) and clinical characteristics are reported, though sex distribution is not explicitly given.

Evidence

“The median age of the patients was 59 years (range 18–96 years).”

Results ¶1Find in source

absence[Results, paragraph 1]

Sex of patients is not reported.

paraphrase[Table 1]

PASSReviewer 2· 90% conf

Patient demographics and clinical characteristics are reported, including age, sex distribution, and disease categories.

Evidence

“The median age of the patients was 59 years (range 18–96 years).”

Results ¶1Find in source

paraphrase[Table 1]

absence[Results, paragraph 1]

Sex of patients is not reported.

The paper states that the study used retrospective de-identified data outside IRB oversight, and informed consent was obtained from physicians. However, no named IRB or ethics committee is mentioned, and the justification for exemption is brief. Regulatory compliance with the Declaration of Helsinki is stated. For human subjects research, both ethics approval and consent are needed; here consent for physicians is mentioned, but patient data exemption is not fully documented.

Sub-criteria

iacuc statementN/A

informed consentINADEQUATE

irb ethics statementINADEQUATE

regulatory complianceADEQUATE

Per reviewer (2) — the votes behind the verdict

WARNReviewer 1· 90% conf

The study involves retrospective de-identified patient data and physician participants; ethics approval is claimed to be outside IRB oversight, but no named IRB or explicit waiver is provided.

Evidence

“This study used only retrospective, de-identified data that fell outside the scope of institutional review board oversight.”

EthicsFind in source

“Informed consent was obtained from each physician before their participation.”

EthicsFind in source

“This study adhered to the principles outlined in the Declaration of Helsinki.”

EthicsFind in source

WARNReviewer 2· 80% conf

The study states adherence to the Declaration of Helsinki and informed consent for physicians, but lacks a named IRB approval and incorrectly claims the data fall outside IRB oversight.

Evidence

“This study adhered to the principles outlined in the Declaration of Helsinki. Informed consent was obtained from each physician before their participation.”

EthicsFind in source

absence[Methods, Ethics approval]

No named IRB approval is provided.

“This study used only retrospective, de-identified data that fell outside the scope of institutional review board oversight.”

EthicsFind in source

AMIE is described as built on Gemini 2.0 Flash, and the inference process is detailed in supplementary. The clinical data are described. No antibodies, cell lines, or organisms are used. Reagents are not applicable. Software tools (Python version) are identified. The investigational product is adequately described.

Sub-criteria

mycoplasma testingN/A

reagents identifiedN/A

organisms identifiedN/A

antibodies identifiedN/A

cell line authenticationN/A

software tools identifiedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 85% conf

The investigational product (AMIE) is described, and software tools are identified; no wet-lab reagents are used.

Evidence

“AMIE was built on top of Gemini 2.0 Flash without any additional domain-specific fine-tuning.”

MethodsFind in source

“All analyses were conducted using Python v.2.7.18 ( https://www.python.org/ ).”

Data availabilityFind in source

PASSReviewer 2· 85% conf

The investigational product (AMIE) is described, and the software used for analysis is identified, though version details are incomplete.

Evidence

“AMIE was built on top of Gemini 2.0 Flash without any additional domain-specific fine-tuning.”

MethodsFind in source

“All analyses were conducted using Python v.2.7.18 ( https://www.python.org/ ).”

Data availabilityFind in source

absence[Methods]

No antibodies, cell lines, or organisms are used.

Two-proportion z-tests and McNemar's tests are named. Exact p-values are reported (e.g., P = 0.02). Effect sizes are reported as percentages with differences and CIs (bootstrapped). Software is identified. Data presentation includes proportions with CIs. Mathematical plausibility checks: percentages sum to ~100% in Table 1 (e.g., 20.6+19.6+7.5+10.3+10.3+10.3+19.6 = 98.2, not exactly 100, but likely rounding). No arithmetic errors detected.

Sub-criteria

tests namedADEQUATE

exact p valuesADEQUATE

effect sizes ciADEQUATE

data presentationADEQUATE

software identifiedADEQUATE

assumptions verifiedINADEQUATE

mathematical plausibilityPASS

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 80% conf

Statistical tests are named, p-values are exact, and effect sizes with CIs are reported; assumptions are not explicitly verified but standard methods are used.

Evidence

“we used two-proportion z -tests to compare the selection frequencies of cardiologist + AMIE versus cardiologist alone for each criterion.”

Statistical analysisFind in source

“subspecialists preferring 46.7% of all cases compared to 32.7% for unassisted cardiologists ( P = 0.02).”

ResultsFind in source

“with error bars indicating 95% confidence intervals computed by bootstrapping the scenarios n = 10,000 times.”

Figure 3Find in source

PASSReviewer 2· 80% conf

Statistical tests are named, p-values are exact, and effect sizes with CIs are reported, though some assumptions are not explicitly verified.

Evidence

“we used two-proportion z -tests to compare the selection frequencies of cardiologist + AMIE versus cardiologist alone for each criterion.”

Statistical analysisFind in source

“subspecialists preferring 46.7% of all cases compared to 32.7% for unassisted cardiologists ( P = 0.02).”

ResultsFind in source

“Error bars in Fig. represent 95% confidence intervals derived from bootstrapping ( n = 10,000).”

Statistical analysisFind in source

Data availability statement names a concrete repository (Redivis) with a URL and license. Code availability describes the inference process and Python version, but no public code repository is provided. For a clinical dataset, repository deposit is adequate. Accession numbers are not applicable. Code sharing is partially adequate.

Sub-criteria

code sharingINADEQUATE

accession numbersN/A

repository depositADEQUATE

data availability statementADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

Data are openly available with a URL and license, and code is described; no accession numbers are needed.

Evidence

“All data are open-source and are available at https://redivis.com/datasets/1z3x-2354972da?v=next . Data are licensed under open-source license CC 4.0”

Data availabilityFind in source

“The inference process used to generate assessments is detailed in Supplementary Section , while the prompt used in the conversational interface is presented in Supplementary Section .”

Data availabilityFind in source

PASSReviewer 2· 90% conf

Data are openly available with a URL and license, and code availability is described, though the code repository is not explicitly linked.

Evidence

“All data are open-source and are available at https://redivis.com/datasets/1z3x-2354972da?v=next . Data are licensed under open-source license CC 4.0 (http://creativecommons.org/licenses/by/4.0/) .”

Data availabilityFind in source

“The inference process used to generate assessments is detailed in Supplementary Section , while the prompt used in the conversational interface is presented in Supplementary Section . All analyses were conducted using Python v.2.7.18 ( https://www.python.org/ ).”

Data availabilityFind in source

Trial registration is provided (NCT06935253). CONSORT guidelines are mentioned. All pre-specified outcomes are reported, including negative results (e.g., no difference in extra content). Limitations are extensively discussed. Conclusions are proportional, acknowledging the need for prospective studies. Funding and COI are disclosed.

Sub-criteria

funding coiADEQUATE

trial registrationADEQUATE

reporting guidelineADEQUATE

methods completenessADEQUATE

all outcomes reportedADEQUATE

limitations discussedADEQUATE

conclusions proportionalADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 85% conf

The paper follows CONSORT, is registered, discusses limitations, and reports funding/COI; all outcomes are reported.

Evidence

“is registered at ClinicalTrials.gov ( NCT06935253 (http://clinicaltrials.gov/ct2/show/NCT06935253) )”

Methods ¶1Find in source

“Our RCT followed the CONSORT RCT guidelines”

Methods ¶1Find in source

“Our study contains a number of important limitations, and the findings should be interpreted with appropriate caution and humility.”

Discussion ¶7Find in source

PASSReviewer 2· 85% conf

The paper follows CONSORT, is registered, discusses limitations, and reports funding and COI, though not all outcomes are pre-specified.

Evidence

“Our RCT followed the CONSORT RCT guidelines and is registered at ClinicalTrials.gov ( NCT06935253 (http://clinicaltrials.gov/ct2/show/NCT06935253) ).”

MethodsFind in source

“Our study contains a number of important limitations, and the findings should be interpreted with appropriate caution and humility.”

Discussion ¶7Find in source

“This study was funded by Alphabet Inc. and/or a subsidiary thereof (‘Alphabet’).”

Competing interestsFind in source

Registered (1 ID: ClinicalTrials.gov). Reporting guideline cited: CONSORT.

Broken references and links

None found

References checked against Crossref, OpenAlex and Retraction Watch for retractions and resolvability, plus declared data and code links probed for whether they resolve to content matching the paper.

Checked — nothing surfaced.

Checked 45 references by DOI: 36 verified — 9 no DOI (shown, not verified).

2 data/code links checked; 2 live.

Copyediting

6 minor

Wording, consistency and formatting errors that need correcting before submission.

No major wording or formatting errors. 6 minor suggestions below.

6 copyedit issues flagged: mostly consistency, clarity, other.

Kaimen Rigor Action ItemsFinal pass before journal submission

The published paper is robust to informed reading: the core design and analysis are sound and transparently reported. An informed reader should weigh the following: (1) the absence of a named IRB and the assertion that the data fall outside IRB oversight is a regulatory determination that is not documented; (2) sex is not reported; (3) no power analysis is reported; (4) the code repository is not public; (5) the trial was registered after the study start date (retrospective registration). None of these invalidate the findings, but items (1) and (5) would warrant an erratum or a note from the authors, and items (2)-(4) are reporting gaps an informed reader should weigh.

1.
HIGHethics
Add a named IRB or ethics committee approval with a protocol number to the Ethics approval section, or document the formal determination that the data fell outside IRB oversight.
The current statement asserts the data fall outside IRB oversight without documenting the determination; a named IRB or a documented exemption determination is the standard for human-subjects research.
2.
HIGHreporting
Report the sex distribution of the patient cohort in Table 1 or the Results section.
Sex is a core biological variable in a human clinical study; its omission is a reporting gap that prevents assessment of sex-based effects.
3.
HIGHreporting
Add a power analysis or sample-size justification to the Methods section.
No power analysis is reported; a pilot with a fixed sample still warrants a justification of the sample size.
4.
HIGHdata code
Provide a public link to the analysis code repository (e.g., GitHub) in the Code availability section.
The code is described but not deposited; a public repository would make the analysis reproducible.
5.
HIGHreporting
Clarify whether the trial was registered prospectively or retrospectively, and note the registration date relative to the study start date.
The registration (NCT06935253) appears to have been submitted after the study start date (2025-01-10); prospective vs retrospective registration is a material reporting detail.
6.
MEDIUMstatistics
State the statistical assumptions for the two-proportion z-test and McNemar's test, and how they were verified.
Assumptions are not explicitly verified; stating them improves reproducibility.
7.
MEDIUMdata code
Correct the Python version in the Code availability section (likely Python 3.x, not 2.7.18).
Python 2.7 is end-of-life; the version is likely a typo.
8.
MEDIUMreporting
State the inclusion/exclusion criteria for patient selection explicitly in the Methods section.
The criteria are implicit (consecutive patients); explicit criteria improve reproducibility.
9.
MEDIUMreporting
Reconcile the 93.4% vs 93.5% discrepancy for the same metric (AMIE did not miss anything).
The paper reports 93.4% in one place and 93.5% in another for the same result; the numbers should be consistent.
10.
MEDIUMreporting
Clarify the 1.9% of cases not accounted for in the hallucination percentages (91.6% + 6.5% = 98.1%).
The percentages do not sum to 100%; the residual 1.9% should be explained or the numbers corrected.
11.
LOWcopyedit
Fix the subject-verb agreement in the Data availability section ('Data consists of...' → 'Data consist of...').
Minor grammar issue flagged by the copyedit pass.
12.
LOWcopyedit
Add a space in 'two-proportion z-tests' for consistency.
Minor formatting consistency.
13.
LOWcopyedit
Ensure consistent capitalization of 'P' vs 'p' for p-values across the manuscript.
The abstract uses 'P' while the text uses 'p'; standardize.

Full text (54,385 chars)Analyzed: Aug 15, 2026

Start the discussion on JRNLClub

Community discussion on jrnlclub.com

Read alongside

A large language model for complex cardiology care.

Read full text (PMC)

DOI

10.1038/s41591-025-04190-9

Share this Kaimen Rigor review

Post on X Share on LinkedIn Share via Email

Embed this Rigor badge

<a href="https://alpha1science.com/verify/8ab6e220-12e8-4828-b456-b9f6a160a566" target="_blank" rel="noopener">
  <img src="https://alpha1science.com/verify/8ab6e220-12e8-4828-b456-b9f6a160a566/badge" alt="Kaimen Rigor review — 1.75★ (Critical), 0 critical, 5 high issues for “A large language model for complex cardiology care.”" width="440" height="104" style="max-width:100%;height:auto" />
</a>

Every embed links back to this Kaimen Rigor review.

Record fingerprint

9da080894bcc5d7e9e269642c089bd6597ba779e149534d2492d9bb6f32796e3

Verify via API

Issued Aug 15, 2026Engine 7.39.0

Alpha1 assesses methodological rigor, not the importance of the findings. See how we calibrate →

Kaimen Rigor review

Kaimen Rigor reviewed

1.75 / 5

Critical — serious problems across many checks

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×4−2★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
ClaimsTreatment effect not shown to be clinically meaningful−0.5★
ReportingEthical approvals partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Biggest issues

01Efficacy rests on an unvalidated surrogate endpoint
highOverreachreviewer-assessedFull detail
The primary efficacy claim is that AMIE-assisted cardiologists produce 'preferable' assessments, with fewer errors and missing content, as rated by subspecialists. This is a surrogate outcome (subspecialist preference and error counts) rather than a hard clinical outcome. The paper does not demonstrate target engagement (e.g., PK/PD) nor cite validated evidence linking these surrogate measures to improved patient outcomes. The authors acknowledge this limitation: 'preference-based evaluation cannot definitively establish real-world clinical benefit.'
“preference-based evaluation cannot definitively establish real-world clinical benefit”
Find in source
02Treatment effect not shown to be clinically meaningful
highOverreachreviewer-assessedFull detail
The reported effect sizes are modest and not anchored to a minimal clinically important difference or clinical meaningfulness. For example, overall preference was 46.7% vs 32.7% (a 14% absolute difference), and error rates were 13.1% vs 24.3% (an 11.2% difference). These are statistically significant but the clinical significance is not established. The paper does not provide a benchmark for what constitutes a clinically meaningful improvement in these surrogate measures.
“subspecialists favored large language model-assisted responses overall, and for the management plan and diagnostic testing domains, with the remaining domains considered a tie”
Find in source
03Other integrity concern
mediumAuthenticityreviewer-assessedFull detail
Trial NCT06935253 was first submitted to ClinicalTrials.gov on 2025-04-11, after the registered study start date of 2025-01-10. Retrospective registration means the protocol and outcomes were not on the public record before the study ran, which is what prospective registration exists to establish.
NCT06935253
reviewer’s wording

Findings by category

101ArithmeticNumerical inconsistencies 302OverreachOverstated conclusions 103AuthenticityData authenticity concerns 104DisclosureReporting gaps 05AvailabilityNone found 06Copyedit6 minor suggestions

A well-conducted and well-reported RCT of LLM assistance for general cardiologists, with minor reporting gaps (sex not reported, no named IRB, no power analysis, code repository not linked).

Numerical inconsistencies

1 finding · worst low

Internal contradictions in the reported numbersAssessed

Recomputed 6 tests: 6 consistent, 0 inconsistent; 6 via agent-written checks.

Overstated conclusions

3 findings · worst high

Efficacy rests on an unvalidated surrogate endpointAssessed
Treatment effect not shown to be clinically meaningfulAssessed
Conclusions only partially backed by the presented evidenceAssessed

9 major claims checked against the paper's own evidence: 1 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Premise concern: surrogate not validated for clinical benefit; effect size not shown to be clinically meaningful.

Data authenticity concerns

1 finding · worst medium

Other integrity concernAssessed

4 integrity concerns flagged (0 high).

Reporting gaps

1 finding · worst medium

Ethics/consent reporting incompleteAssessed

Eight Dimensions7 pass · 1 warn

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear premise: scarcity of subspecialist expertise, and prior work on LLMs in medicine is cited, with gaps identified.

Evidence

“Despite more than 500 observational LLM papers published in 2024, systematic reviews of LLMs in medicine have consistently shown a lack of RCTs”

Discussion ¶5Find in source

“This study probes the potential of LLMs to democratize subspecialist-level expertise by focusing on an indicative example: the domain of genetic cardiomyopathies like HCM.”

Introduction ¶4Find in source

“Compared to earlier studies relying on simulated or text-only data, our design represents a substantial advancement toward real-world clinical applicability.”

Introduction ¶4Find in source

PASSReviewer 2· 90% conf

The paper establishes a clear premise of subspecialist scarcity and the potential of LLMs, citing prior work and limitations.

Evidence

Introduction ¶2Find in source

“This study probes the potential of LLMs to democratize subspecialist-level expertise by focusing on an indicative example: the domain of genetic cardiomyopathies like HCM.”

Introduction ¶3Find in source

“Compared to earlier studies relying on simulated or text-only data, our design represents a substantial advancement toward real-world clinical applicability.”

Introduction ¶3Find in source

Sub-criteria

controlsADEQUATE

power analysisNOT REPORTED

blinding levelsADEQUATE

outlier handlingNOT REPORTED

randomization unitADEQUATE

inclusion exclusionINADEQUATE

randomization methodINADEQUATE

replicate distinctionN/A

independent replicationN/A

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 85% conf

The RCT design is well-described: randomization of cardiologists, blinding of subspecialist evaluators, and a pre-specified analysis plan.

Evidence

“One of the two general cardiologists was randomized to complete the assessment with the assistance of AMIE.”

MethodsFind in source

“The subspecialists were blinded to the source of each assessment, and the assessments were provided in a randomized order.”

MethodsFind in source

absence[Methods, Statistical analysis]

No power analysis is reported.

PASSReviewer 2· 85% conf

The RCT design is rigorous with randomization, blinding of evaluators, and a pre-specified analysis, though some details like allocation concealment are not reported.

Evidence

“One of the two general cardiologists was randomized to complete the assessment with the assistance of AMIE.”

MethodsFind in source

“The subspecialists were blinded to the source of each assessment, and the assessments were provided in a randomized order.”

MethodsFind in source

absence[Methods, Statistical analysis]

No power analysis is reported.

Sub-criteria

demographicsINADEQUATE

sex reportedNOT REPORTED

sex justifiedN/A

age weight healthADEQUATE

housing conditionsN/A

species strain sourceN/A

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 80% conf

Patient demographics (age, sex) and clinical characteristics are reported, though sex distribution is not explicitly given.

Evidence

“The median age of the patients was 59 years (range 18–96 years).”

Results ¶1Find in source

absence[Results, paragraph 1]

Sex of patients is not reported.

paraphrase[Table 1]

PASSReviewer 2· 90% conf

Patient demographics and clinical characteristics are reported, including age, sex distribution, and disease categories.

Evidence

“The median age of the patients was 59 years (range 18–96 years).”

Results ¶1Find in source

paraphrase[Table 1]

absence[Results, paragraph 1]

Sex of patients is not reported.

Sub-criteria

iacuc statementN/A

informed consentINADEQUATE

irb ethics statementINADEQUATE

regulatory complianceADEQUATE

Per reviewer (2) — the votes behind the verdict

WARNReviewer 1· 90% conf

The study involves retrospective de-identified patient data and physician participants; ethics approval is claimed to be outside IRB oversight, but no named IRB or explicit waiver is provided.

Evidence

“This study used only retrospective, de-identified data that fell outside the scope of institutional review board oversight.”

EthicsFind in source

“Informed consent was obtained from each physician before their participation.”

EthicsFind in source

“This study adhered to the principles outlined in the Declaration of Helsinki.”

EthicsFind in source

WARNReviewer 2· 80% conf

The study states adherence to the Declaration of Helsinki and informed consent for physicians, but lacks a named IRB approval and incorrectly claims the data fall outside IRB oversight.

Evidence

“This study adhered to the principles outlined in the Declaration of Helsinki. Informed consent was obtained from each physician before their participation.”

EthicsFind in source

absence[Methods, Ethics approval]

No named IRB approval is provided.

“This study used only retrospective, de-identified data that fell outside the scope of institutional review board oversight.”

EthicsFind in source

Sub-criteria

mycoplasma testingN/A

reagents identifiedN/A

organisms identifiedN/A

antibodies identifiedN/A

cell line authenticationN/A

software tools identifiedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 85% conf

The investigational product (AMIE) is described, and software tools are identified; no wet-lab reagents are used.

Evidence

“AMIE was built on top of Gemini 2.0 Flash without any additional domain-specific fine-tuning.”

MethodsFind in source

“All analyses were conducted using Python v.2.7.18 ( https://www.python.org/ ).”

Data availabilityFind in source

PASSReviewer 2· 85% conf

The investigational product (AMIE) is described, and the software used for analysis is identified, though version details are incomplete.

Evidence

“AMIE was built on top of Gemini 2.0 Flash without any additional domain-specific fine-tuning.”

MethodsFind in source

“All analyses were conducted using Python v.2.7.18 ( https://www.python.org/ ).”

Data availabilityFind in source

absence[Methods]

No antibodies, cell lines, or organisms are used.

Sub-criteria

tests namedADEQUATE

exact p valuesADEQUATE

effect sizes ciADEQUATE

data presentationADEQUATE

software identifiedADEQUATE

assumptions verifiedINADEQUATE

mathematical plausibilityPASS

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 80% conf

Statistical tests are named, p-values are exact, and effect sizes with CIs are reported; assumptions are not explicitly verified but standard methods are used.

Evidence

“we used two-proportion z -tests to compare the selection frequencies of cardiologist + AMIE versus cardiologist alone for each criterion.”

Statistical analysisFind in source

“subspecialists preferring 46.7% of all cases compared to 32.7% for unassisted cardiologists ( P = 0.02).”

ResultsFind in source

“with error bars indicating 95% confidence intervals computed by bootstrapping the scenarios n = 10,000 times.”

Figure 3Find in source

PASSReviewer 2· 80% conf

Statistical tests are named, p-values are exact, and effect sizes with CIs are reported, though some assumptions are not explicitly verified.

Evidence

“we used two-proportion z -tests to compare the selection frequencies of cardiologist + AMIE versus cardiologist alone for each criterion.”

Statistical analysisFind in source

“subspecialists preferring 46.7% of all cases compared to 32.7% for unassisted cardiologists ( P = 0.02).”

ResultsFind in source

“Error bars in Fig. represent 95% confidence intervals derived from bootstrapping ( n = 10,000).”

Statistical analysisFind in source

Sub-criteria

code sharingINADEQUATE

accession numbersN/A

repository depositADEQUATE

data availability statementADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

Data are openly available with a URL and license, and code is described; no accession numbers are needed.

Evidence

“All data are open-source and are available at https://redivis.com/datasets/1z3x-2354972da?v=next . Data are licensed under open-source license CC 4.0”

Data availabilityFind in source

“The inference process used to generate assessments is detailed in Supplementary Section , while the prompt used in the conversational interface is presented in Supplementary Section .”

Data availabilityFind in source

PASSReviewer 2· 90% conf

Data are openly available with a URL and license, and code availability is described, though the code repository is not explicitly linked.

Evidence

Data availabilityFind in source

Sub-criteria

funding coiADEQUATE

trial registrationADEQUATE

reporting guidelineADEQUATE

methods completenessADEQUATE

all outcomes reportedADEQUATE

limitations discussedADEQUATE

conclusions proportionalADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 85% conf

The paper follows CONSORT, is registered, discusses limitations, and reports funding/COI; all outcomes are reported.

Evidence

“is registered at ClinicalTrials.gov ( NCT06935253 (http://clinicaltrials.gov/ct2/show/NCT06935253) )”

Methods ¶1Find in source

“Our RCT followed the CONSORT RCT guidelines”

Methods ¶1Find in source

“Our study contains a number of important limitations, and the findings should be interpreted with appropriate caution and humility.”

Discussion ¶7Find in source

PASSReviewer 2· 85% conf

The paper follows CONSORT, is registered, discusses limitations, and reports funding and COI, though not all outcomes are pre-specified.

Evidence

“Our RCT followed the CONSORT RCT guidelines and is registered at ClinicalTrials.gov ( NCT06935253 (http://clinicaltrials.gov/ct2/show/NCT06935253) ).”

MethodsFind in source

“Our study contains a number of important limitations, and the findings should be interpreted with appropriate caution and humility.”

Discussion ¶7Find in source

“This study was funded by Alphabet Inc. and/or a subsidiary thereof (‘Alphabet’).”

Competing interestsFind in source

Registered (1 ID: ClinicalTrials.gov). Reporting guideline cited: CONSORT.

Broken references and links

None found

References checked against Crossref, OpenAlex and Retraction Watch for retractions and resolvability, plus declared data and code links probed for whether they resolve to content matching the paper.

Checked — nothing surfaced.

Checked 45 references by DOI: 36 verified — 9 no DOI (shown, not verified).

2 data/code links checked; 2 live.

Copyediting

6 minor

Wording, consistency and formatting errors that need correcting before submission.

No major wording or formatting errors. 6 minor suggestions below.

6 copyedit issues flagged: mostly consistency, clarity, other.

Kaimen Rigor Action ItemsFinal pass before journal submission

1.
HIGHethics
Add a named IRB or ethics committee approval with a protocol number to the Ethics approval section, or document the formal determination that the data fell outside IRB oversight.
The current statement asserts the data fall outside IRB oversight without documenting the determination; a named IRB or a documented exemption determination is the standard for human-subjects research.
2.
HIGHreporting
Report the sex distribution of the patient cohort in Table 1 or the Results section.
Sex is a core biological variable in a human clinical study; its omission is a reporting gap that prevents assessment of sex-based effects.
3.
HIGHreporting
Add a power analysis or sample-size justification to the Methods section.
No power analysis is reported; a pilot with a fixed sample still warrants a justification of the sample size.
4.
HIGHdata code
Provide a public link to the analysis code repository (e.g., GitHub) in the Code availability section.
The code is described but not deposited; a public repository would make the analysis reproducible.
5.
HIGHreporting
Clarify whether the trial was registered prospectively or retrospectively, and note the registration date relative to the study start date.
The registration (NCT06935253) appears to have been submitted after the study start date (2025-01-10); prospective vs retrospective registration is a material reporting detail.
6.
MEDIUMstatistics
State the statistical assumptions for the two-proportion z-test and McNemar's test, and how they were verified.
Assumptions are not explicitly verified; stating them improves reproducibility.
7.
MEDIUMdata code
Correct the Python version in the Code availability section (likely Python 3.x, not 2.7.18).
Python 2.7 is end-of-life; the version is likely a typo.
8.
MEDIUMreporting
State the inclusion/exclusion criteria for patient selection explicitly in the Methods section.
The criteria are implicit (consecutive patients); explicit criteria improve reproducibility.
9.
MEDIUMreporting
Reconcile the 93.4% vs 93.5% discrepancy for the same metric (AMIE did not miss anything).
The paper reports 93.4% in one place and 93.5% in another for the same result; the numbers should be consistent.
10.
MEDIUMreporting
Clarify the 1.9% of cases not accounted for in the hallucination percentages (91.6% + 6.5% = 98.1%).
The percentages do not sum to 100%; the residual 1.9% should be explained or the numbers corrected.
11.
LOWcopyedit
Fix the subject-verb agreement in the Data availability section ('Data consists of...' → 'Data consist of...').
Minor grammar issue flagged by the copyedit pass.
12.
LOWcopyedit
Add a space in 'two-proportion z-tests' for consistency.
Minor formatting consistency.
13.
LOWcopyedit
Ensure consistent capitalization of 'P' vs 'p' for p-values across the manuscript.
The abstract uses 'P' while the text uses 'p'; standardize.

Full text (54,385 chars)Analyzed: Aug 15, 2026